current user: public

If you have questions about the server, please let us know.

Query: sp|Q5VV42|CDKAL_HUMAN CDK5 regulatory subunit-associated protein 1-like 1 OS=Homo sapiens GN=CDKAL1 PE=1 SV=1, from H.sapiens

Results of FFAS03 search in PDB1018
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .
# Score Template Links and tools%idFirst MPSASCDTLLDDIEDIVSQEDSKPQDRHFVRKDVVPKVRRRNTQKYLQEEENSPPSDSTIPGIQKIWIRTWGCSHNNSDGEYMAGQLAAYGYKITENASDADLWLLNSCTVKNPAEDHFRNSIKKAQEENKKIVLAGCVPQAQPRQDYLKGLSIIGVQQIDRVVEVVEETIKGHSVRLLGQKKDNGRRLGGARLDLPKIRKNPLIEIISINTGCLNACTYCKTKHARGNLASYPIDELVDRAKQSFQEGVCEIWLTSEDTGAYGRDIGTNLPTLLWKLVEVIPEGAMLRLGMTNPPYILEHLEEMAKILNHPRVYAFLHIPVQSASDSVLMEMKREYCVADFKRVVDFLKEKVPGITIATDIICGFPGETDQDFQETVKLVEEYKFPSLFINQFYPRPGTPAAKMEQVPAQVKKQRTKDLSRVFHSYSPYDHKIGERQQVLVTEESFDSKFYVAHNQFYEQVLVPKNPAFMGKMVEVDIYESGKHFMKGQPVSDAKVYTPSISKPLAKGEVSGLTKDFRNGLGNQLSSGSHTSAASQCDSASSRMVLPMPRLHQDCALRMSVGLALLGLLFAFFVKVYNLast
1 -90.4004jc0_A mol:protein length:438 Ribosomal protein S12 methylthiotransferase RimO  ali model follow..  25  1...............................................................MRVGIKVLGCPKNEADCEVLAGVLREGGHEIVFDVKDADVVVLDTCAFIEDAKRESIDEIFSFVDAKDKLVVKGCLVQRYYEELIPEVDQWIGVADPEEIANAIENGTDLVPDQPETVYRYRKR----------IDLEERPYAYVKISDGCDRGCTFCSIPSFKGSLRSRSIEDITREVEDLLKEGKKEIILVAQDTTSYGIDLKQALPDLLRRL-NSLNGEFWIRVMYLHPDHLTEEIISA--MLELDKVVKYFDVPVQHGSDKILKLMGRTKSSEELKKMLSSIRERFPDAVLRTSIIVGFPGETEEDFEELKQFVEEIQFDKLGAFVYSDEEGTVAFNLEKVDPEMAKRRQEELLLLQAEISNSRLFVGKKLKFLVEG--KEGKFLVGRTWTEAPVVFVRGKGKIGDFLEVVIKEHDEYDMWGSVILE..................................................................................... 432
2 -22.9006fd2_B mol:protein length:457 Putative apramycin biosynthetic oxidoreductase 4  ali model follow..  12  48.................................................................................RLAGVLREDADDITGVVPSVEPGTTVICHVSLPSLLEDAERLATFRAQGARYAYTSIRSPAQWRTLFGGCEGVLLPESISFARAALAGDHTVPGLVTPDSLLDPRHHQPDHTPYMFPPIARTGITSINGSFGCPYPCRFYCPYPL--KIRTYPVERIVAEFRQCAELGITAAVFR-DPVFSFHRDRTLELCQALKAADTGVPWWCETRIDR-----LDEEVVAALVDAG----CVGVEVGVESGDPDMATAVRKRLNLDTVRKFHAVARKA--GLKLVFLFLIGLPRETRMSIRRTFDFILELGLADTNLSVITPYPGTAVMHTDELSIGDLERASRFVDELHAVCKAGPAERAEFQARV.......................................................................................................................................... 449
3 -22.3005ul2_A mol:protein length:744 OxsB protein  ali model follow..  13  142.................................................................................TLSSYLRKEQLAKVELDSQPDIIGLSVNFGQKKLAFEILDLIYSHIENSSIITVGNVIPSFSPEQFFERSLLICGEYTLRDLIKMLKKELKLDEVNGISYVDESGEVKHNVAETVNFKEEVPTPSLLETSRGC-SRCTFCPRDHKLRSWRPLSVEQTLKQLDDILRAGMADEEFIGELPNGTEAQRIIDICEGLLKREEKIKFDFAARADSVYEPKRTKEWLKMWHYCALA--ADRIFIGVESGSNQQLKRYGKGTTSEQNIIALRLVSAL--GINLRIGIMFDQLMKGLDNLKENLDFLERTDALMK-PIDIGDMTYEELYD............................................................................................................................................................................... 515
4 -18.4005l7j_A mol:protein length:459 ELP3 family  ali model follow..  14  13...........................................................................................................................................................................................................PVAVMTKPLPCPGKCIYCPTFAATPQSYTQAYKQVALRLRIIQDMGHPELIIMGGTFLSADITYQYGFIKDCYDALNAQHRCVGLCIET-RPDICGKAEIQRMIDFGTTRV----ELGVQMLDDDIYKLVERGHRVSDVAEATCLLREY--GLKVHYHWMPGLPGSSPEKDLALSRMVFEFCPDGLKLYPTMVVEGTIEGRYTPYPNGTMTGLIADIKALVPPYVRISRVLRD............................................................................................................................................... 281
5 -18.1005l7l_A mol:protein length:446 ELP3 family, ELP3 family  ali model follow..  13  13...........................................................................................................................................................................................................PVAVMTKPLPCPGKCIYCPTFAATPQSYTPESPAVLRAKSCEYQTDKVELIIMGGTFLSADITYQYGFIKDCYDALNAQHRCVGLCIET-RPDICGKAEIQRMIDFGTTRV----ELGVQMLDDDIYKLVERGHRVSDVAEATCLLREY--GLKVHYHWMPGLPGSSPEKDLALSRMVFEFCPDGLKLYPTMVVEGTILEQWTPYPNGTMTGLIADIKALVPPYVRISRVLRD............................................................................................................................................... 281
6 -18.1004jy8_A mol:protein length:358 FEFE-HYDROGENASE MATURASE  ali model follow..  18  10............................................................................................................................................................ASTGREILEKLERREFTREVLKEALSINDRGFNEALFKLADEIRRKHIRAIIEFSNVCRKNCLYCGLRRDNKNLKRYTPEEIVERARLAVQFGAKTIVLQSGEDPYYMPDVISDIVKEIKKMGVAV-----LSLGEWPREYY-EKWKEA---------ADRYLLRHETANPVLHRKLRPDTSFENRLNCLLTLKEL--GYETGAGSMVGLPGQTIDDLVDDLLFLKEHDFDMVGIGPFIPHPDTPLANEKKGDF----TLTLKMVALTRILLPDSNIPATTAMGTIVPGGREITLRCGANV.......................................................................................................................... 299
7 -17.7005fep_A mol:protein length:358 [FeFe] hydrogenase maturase subunit HydE  ali model follow..  18  14................................................................................................................................................................REILEKLERREFTREVLKEALSINDRGFNEALFKLADEIRRKHIRAIIEFSNVCRKNCLYCGLRRDNKNLKRYTPEEIVERARLAVQFGAKTIVLQSGEDPYXMPDVISDIVKEIKKMGVAV-----LSLGEWPREYY-EKWKEA---------ADRYLLRHETANPVLHRKLRPDTSFENRLNCLLTLKEL--GYETGAGSMVGLPGQTIDDLVDDLLFLKEHDFDMVGIGPFIPHPDTPLANEKKGDF----TLTLKMVALTRILLPDSNIPATTAMGTIVPGGREITLRCGANV.......................................................................................................................... 299
8 -16.6003t7v_A mol:protein length:350 methylornithine synthase PylB  ali model follow..  15  1.........................................................................................................................................................MIQKMALDEFDSLGDKVIEGYQLLRTLLSLESKEGLERLYSAARKVRDHFLNCFIYFSTYCKNQCSFCYYNCRNEINRYRTMEEIKETCKTLKGAGFHMVDLTMGEDPYYYEDPN-RFVELVQIVKEELGLPIMISPGLMD----NATLLKAREKG-----ANFLALYQETYDTELYRKLRVGQSFDGRVNARRFAKQQ--GYCVEDGILTGV-GNDIESTILSLRGMSTNDPDMVRVMTFLPQEGTPLEGFRDKSNLSELKIISVLRLMFPKRL....................................................................................................................................................... 273
9 -15.9001olt_A mol:protein length:457 OXYGEN-INDEPENDENT COPROPORPHYRINOGEN III OXIDASE  ali model follow..  14  45...................................................................................................................................................................................................VARYPERPLSLYVHI---CHKLCYFCKIVTRQQHKADQYLDALEQEIVHRAPRHVSQLHWGGGTPTYLNKA---QISRLMKLLRENFQFNADAEISIVDPREIELDVLDHLRAEGFNRL----SMGVQDFNKEVQRLVNREQDEEFIFALLNHAREI----STNIDLIYGLPKQTPESFAFTLKRVAELNPDRLSVFNYAHLPTIFAAQRKI-SPQQKLDILQETIAFLTQSGYQFIGMDHFARAVAQREGVLHRNFQGYTTQGDTDLLGMGVSAISMIGDCYAQNQKELKQYYQQVDEQGN.................................................................................. 355
10 -15.8004u0o_B mol:protein length:296 Lipoyl synthase 2  ali model follow..  13  50.........................................................................................................................................................................................................GQKTATFLLLGPCTRACAFCQVE-KGHAPAAVDPEEPTKIAAAVATLGLRYVVLTSVARDDLPDQGAGQFVATMAAIRQRCPG---TEIEVLSPDFRMDRGRDCIAQIVAAQPACYNH--LET-VRRLQGPVRRGATYESSLRVLATVKELNPDIPTKSGLMLGL-GETEAEIIETLKDLRRVGCDRLTLGQYLPPSLSHLPVVKYWTPEE--------FNTLGNIARELGF-----SHVRSGPLVRSSYHAAEG........................................................................................................................... 289
11 -13.9005exi_A mol:protein length:331 Lipoyl synthase  ali model follow..  12  83..........................................................................................................................................................................................................DREATFLIGGDCTRRCDFC--QIDTGKPAELDRDEPRRVADSVRTMGLRYATVTGVARDDLPDGGAWLYAATVRAIKELNPS---TGVELLIPDFNGEP--TRLAEVFESGPEVLAH--VET-VPRIFKRIRPAFTYRRSLGVLTAARD--AGLVTKSNLILGL-GETSDEVRTALGDLRDAGCDIVTITQYLRPSARHHPVERWVKPEEFVQFARFAEGLGFAGVLAGPLV................................................................................................................................................. 303
12 -13.4004wcx_A mol:protein length:480 Biotin and thiamin synthesis associated  ali model follow..  1..............................................................................................................MGSSSQDPMVKEKADFINDEKIRQDLEKAKKATSKDALEIIEKAKNLKGIEEAAVLLNVEDEDLLNEMFKVARYIKEEIYGNRIV--------IFAPLYVSNYCVNNCRYCGYRHSNEQQRKKTMEEVRREVEILEEMGHKRLAVEGEDPVNCPIDY---IVDVIKTIYDTKLKNGSIRRVNVNIAATTVENYKKLKKVGIGT----YVLFQETYHRPTYEYMHPQGPKHDYDYHLTAMDRAME-DDVGLGVLYGLYDYKYETVAMLYHANHLEE-HTISVPRLRPALNISIDKFPYIVSDKDFKKLVAVIRM............................................................................................................................................................ 309
13 -13.3002a5h_A mol:protein length:416 L-lysine 2,3-aminomutase  ali model follow..  14  110......................................................................................................................................................................................................THRYPDRVLLLITDMCSMYCRHCTRRRFAGQSDDSMPMERIDKAIDYIRNQVRDVLLSGGDALLVS---DETLEYIIAKL-REIPHVEIVRIGSVLPQRITPELVNMLKKYHPVWLNTHFNHPNE--------------ITEESTRACQLLADAGVPLGNQSVLLRGV-NDCVHVMKELVNKLVKIRVRPYYIYQCDLSLGLEHFRTPSKGIEIIEGLRGHTSGYCVPVVDAPGGGGKTPVMPNYVISQSHDKVILRNFEGVITTYSEP................................................................................................................ 368
14 -13.1004rtb_A mol:protein length:477 HydG protein  ali model follow..  13  1..........................................................................MGSSSSGLVPRGSHMTQEIITLVQRTYEIV-----KVNRNPKEEISQIIQKLQKGERL--------------SLIEAGIAFANDTEELDQILFWQARKVKEEIY---------------------KRIVLFAPLYLSNICINNCSYCSFRRENKELSRVSLEEAVDEAKAIREMGHTRILLVM------GEEPEDKTLSYLEEIIPAISEVDIRRINVNIAPLTLKGYERLKKL------IGTYQLFQESYNPEVYREVHLDGPKTNFLWRLNAVERAIE-DDIGIGALFGL-GDPLFELLGVIAHADYLK-HTVSVPRLKPALNSVFSNDYKISDHK---KIVALLRI............................................................................................................................................................ 309
15 -12.9006b4c_A mol:protein length:298 Viperin  ali model follow..  15...............................................................................................................................................................................................................YHFSRKCNKECLFCFHTATTSHVEK--PENAKRGLTLLKQAGMKKINFAG------GEPLYPKFLGEMIDFCKETLQLESVSI-VTNGSLVKEQFLQKHG-----RNIDILAVSCDSFNEATNIKIGRG-NVQKLYEIGSWCQKYDIKFKLNTVVN---KFNHLEDMNDHLNALQPFRWKCFQVLIVTGENDSDKTLRNAHSLTISDDEFDRFCERHSSQT....................................................................................................................................................... 221
16 -12.9005vsl_A mol:protein length:318 Radical S-adenosyl methionine domain-containing protein 2  ali model follow..  15  26.......................................................................................................................................................................................................RTTPVSVNYHFTRQCNYKCGFCFHT--AKTSFVLPLEEAKRGLLLLKQAGLEKINFSG------GEPFLQDRGEYLGKLVRFCKEELALP--VSNGSLIRERWFKDYG-----EYLDILAISCDSFDEQVNALIGRGQGKKNHVENLQKLRRWCRDYKVAFKISVINRFNVDEDMNEHIKALSPVRWKVFQCLLIEGENSGEDALREAERFLISNEEFETFLERHKEVS....................................................................................................................................................... 244
17 -12.8001r30_A mol:protein length:369 Biotin synthase  ali model follow..  14  9................................................................................................................................................................TTENLYFQGSAHRPRWTLSQVTELFEKPLLDLLFEAQQVHRQHVSTLLSIKTGCPEDCKYCPQSSRYKTGLEAEVEQVLESARKAKAAGSTRFCMGAAWKNPHERDM-----PYLEQMVQGVKAMG-LEACMTLGTLSESQAQRLANAGLDYYNHNL------DTSPEFYGNIITTRTYQERLDTLEKVRDA--GIKVCSGGIVGL-GETVKDRAGLLLQLANLPPESVPINMLVKVKGTPLADNDDVDA----FDFIRTIAVARIMMPTSYVRLSAGREQMNEQTQAMCFMAGANS.......................................................................................................................... 300
18 -11.9004r33_A mol:protein length:420 NosL  ali model follow..  1......................................................................................MGSSSSGLVPRGSHM-TQNSQAMTSHAMTGDFVLPELEDVRAEAATVDTRAVLALAEGEEPAESRAALALWEDRSIGTAELQAAAEARCGAR---------------------PRLHTFVPLYTTNYCDSECKMCSMRKGNHRLDRKGRKEITEQLEILYHHGVRGVGFLGEYEDKHTRLASAFIGWAIRTALDLGFERVYFNIGSMEQDEI-DVLGEWIGREDPVTMCVFQESYDRETYRRFMGKTSVGVPKADFDRRVVSFDRWLD--YVNPGVLVGLHDDLSAELVSLVAHGDHLRSRDLSVPRMRPAMKSRDTTRVGDDDYLRLMSVVAFT.............................................................................................................................................................. 326
19 -10.9005tgs_A mol:protein length:263 7-carboxy-7-deazaguanine synthase  ali model follow..  11  20.................................................................................................................................................................PVLEIFGPTIQGEGMVI-----------------------GQKTMFVRTA-GCDYSCSWCDSAFTKKDIRWMTAEEIFAELKDIGGDAFSHVTISGGN-------LLKQLDAFIELLKEN----AALETQGTVYQDWFTLI-------------DDLTISPKPPSSKMVTNF------QKLDHILTSLQENDRQHAVSLKVVIF----NDEDLEFAKTVHKRYPGIPFYLQVGNDD--VHTTDDQSLIAHLLGKYEALVDKVAVDAELNLVRVLPQLHTLLWGNKR.................................................................................................................................... 255
20 -10.8002yx0_A mol:protein length:342 radical sam enzyme  ali model follow..  20..........................................................................................................................................MPKEVAELFRKQHYEIVGRHSGVKLCHWLKKSLTEGRFC--------------YKQKFYGIHSHRCLQMTPVLAWCTHNCIFCNFLGTELPQPWDDPAFIVEESIKAQRKLLIGY---------------KGNPKVDKKKFEEAWNPTHAAISLSGEPMLYPYMGDLVEEFHKRGFPTQLYVSITAPDIETYNSVNIPMIPDGWERILRFLEDLPTRTVVRLTLVKGE---NMHSPEKYAKLILKARPMFVEAKAY-----MFVGYSRNRLTINNMPSHQDIREFAEALVKHLPGYHIEDEVLIMRDDPQGTGVEGRFIKH........................................................................................................................ 342
21 -10.3005v1q_A mol:protein length:459 Radical SAM  ali model follow..  13  120..........................................................................................................................................................................................................PLELVIYPSMYCDLKCGFCFLA-NREDRNAKPAKDWERILRQAKDNGVLSVSILG------GEPT---RYFDIDNLLIACEELKIKTTITTNAQLIKKSTVEILAKSKYITP----VLSLQTLDSKLNFEL-MGVRPDRQIKLAKYFNEVGKKCRINAVYT----KQSYEQIIELVDFCIENKIDRFSVANY-----SEVTGYTKIKKKYDLADLRRLNEYVTDYITQRE................................................................................................................................................... 325
22 -9.9505wgg_A mol:protein length:453 Radical SAM domain protein  ali model follow..  10  1.............................................................................SNAMAMIHKFSMMGTNIVVDVNSGAVHVVD---------DISFDILDYYKNFTAGEIKNKLAHKYNADEI---------DEALREIESLEAEGLLFSEDPYKEYVSSMDRKSVVKAL------------CLHISHDCNLRCKYCFAS-NFGGQRNMMSLEVGKKAIDFLISESGNRKNL--EIDFFGGEPMMNF-DVVKGIIEYARQKKNFRFTTTNGLLLNDENIKYINENM-------QNIVLSIDGRKEVNDRMRIRCYDDILPKFKYVAESRNQDNYYVRGTF---TRENMDFSNDVLHLADEGFRQISVEPVVAAKDSGYDLREEDLPRLFEEYEKLAYEYVKRRKEGNWFNFFHFMIDLTQGPCIVKRLTGCGSGHEYLAVTPE----GDIYPCHQFVGNEKFKMGNVKEG..................................................................................... 382
23 -9.8204fhc_A mol:protein length:368 Spore photoproduct lyase  ali model follow..  16  105...............................................................................................................................................................................................................IPLATGCMGHCHYC---YLQTTLGSKPYIRVYVNLDDIFAQAQKYIFEAACTSDIVGID---HLTHSLKKAIEFIGATDYGRLRFVTKYEHVDHLLDARHNGK-------TRFRFSINSRYVINHFEPG-SFDGRLAAARKVAGAGYKLGFVVAPIYRHEGWERGYFELFQELARQLEGMDLSDLTFELIQHRFTKPAKRVIEQRYPKTRLDLDETKRKYKWGRYGIGK............................................................................................................................................... 330
24 -9.8106c8v_A mol:protein length:394 Coenzyme PQQ synthesis protein E  ali model follow..  19........................................................................................................................................................................................................PAPVGLLAELTHRCPLRCPYCSNPLELDRRSAEDTQTWLRVLTEAAGLGVLHVHLSGGE-------ARPDIVEITAKCAELGLYSNLITSGVGGALAKLDALYDV---------LDHVQLSVQGVDAANAEKIGG--LKNAQPQKMQFAA-RVTELGLPLTLNSVIHRGNIHEVPGFIDLAVKLGAKRLEVAHTQYYGWAYVNRAALMPDKSQVDESIRIVEAARERLKGQLVIDLVVPDYYAKYPKACAGGWGRK----LMNVTPQ----GKVLPCHAAETIPGLEFWYVTDHA.................................................................................... 290
25 -9.7401tv7_A mol:protein length:340 Molybdenum cofactor biosynthesis protein A  ali model follow..  13  18...............................................................................................................................................................................................................LSVTDRCNFRCDYCMPKEVFGKNELLTFDEMARIAKVYAELGVKKIRITGGE-------MRRDLDVLIAKL-NQIDGIEDIGL-TTNGLLLKKHGQKLYDAG-----LRRINVSLDAIDDTLFQSINRNIKATTILEQIDYATSIGLNVKVNVVIQKGI---NDDQIIPMLEYFKDKHIEIRFIEFMDVGNDNGWDFSKVVTKDEMLTMIEQHFEIDPVEPKYFGEVAKYYRH--KDNGVQFGLITSVSQSFCSTCTRARLSSDGKFYGCLFATVDGFNVKAFIRSGVT................................................................................... 297
26 -9.2203rf9_A mol:protein length:404 Ribosomal RNA large subunit methyltransferase N  ali model follow..  12  54.........................................................................................................................................................CDNFDEMTDINKVLRGKLKEVAEIRAPEVVEEQRSSDGTIKWAIAVGDQRVETVVSSQVGCALECKFCST--QQGFNRNLRVSEIIGQVWRAAKRPITNVVMMGMGEPLLNLNNVVPAMEIMLDDFGFGLSKRRVTLSTSGVVPALDKLGDMIDV----ALAISLHAPNDEIRDEIVP-INKKYNIETFLAAVRRYLEKSNAVTIEYVMLDHV-NDGTEHAHQLAELLKDTP--KINLIPWNPFPGAPYGRSSNFTTIVRKTRGDDIDAACGQLAGDV.................................................................................................................................................... 362
27 -9.1506djt_A mol:protein length:331 S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase  ali model follow..  11  2............................................................................................................................................GSSSSGLVPRGSHMIPEEIYKILRKQRYQIDGHTAVKLC-VRKKMLEDKNCYKSKFYGIETHRCIQCTPSVIWCQQNCIFC--PRDIGIDISQIKEPKWEEPEVVYEKILAM--------KRIIMGYAGVLDRVGEKKFKEALEPKHVAISLSGEPTLYPYLDELIKIFHKNGF-TQLYISLDAYDLDSYRRICGKEYWESILNTLDILKEKKRTCIRTTLI-----RGYNDDILKFVELYERADVHFIELKSY-----MHVGYSQKRLKKEDMLQHDEILKLAKMLDENSSY--DSRVALLQNENRK................................................................................................................................... 320

FFAS is supported by the NIH grant R01-GM087218-01
1 3 7 7 9 2   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Sikora S, Godzik A. Combination of multiple alignment analysis and surface mapping paves a way for a detailed pathway reconstruction--the case of VHL (von Hippel-Lindau) protein and angiogenesis regulatory pathway. Protein Sci. 2004 Mar;13(3):786-96. Epub 2004 Feb 06.